<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Primary and secondary myelofibrosis: Management of higher-risk disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Primary and secondary myelofibrosis: Management of higher-risk disease</h1>
<div class="graphic"><div class="figure"><div class="ttl">Primary and secondary myelofibrosis: Management of higher-risk disease</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd"><p>This algorithm describes management of higher-risk primary myelofibrosis and secondary myelofibrosis. None of the available drugs has disease-modifying activity; participation in a clinical trial is encouraged for both symptomatic and asymptomatic patients.</p>
Refer to related UpToDate material for details of diagnosis, risk stratification, fitness for HCT, and treatment.</div><div class="graphic_footnotes"><p>ESA: erythropoiesis-stimulating agent; HCT: hematopoietic cell transplantation; RBC: red blood cell.</p>
* RBC transfusions should be given as needed for relief of anemia-related symptoms during treatment.</div><div id="graphicVersion">Graphic 142768 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
